The announcement of a term sheet with TerraPower for a uranium enrichment facility is a significant development for ASP Isotopes. The deal includes funding and a long-term supply agreement, which are positive indicators for the company's future revenue and growth potential. The non-dilutive nature of the funding is also favorable for shareholders, contributing to the stock's sharp rise.